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ABSTRACT:
The tumour microenvironment has an important role in cancer progression 
and recent reports have proposed that stromal AKT is activated and regulates 
tumourigenesis and invasion. We have shown, by immuno-fluorescent analysis of 
oro-pharyngeal cancer biopsies, an increase in AKT activity in tumour associated 
stromal fibroblasts compared to normal stromal fibroblasts. Using organotypic 
raft co-cultures, we show that activation of stromal AKT can induce the invasion 
of keratinocytes expressing the HPV type 16 E6 and E7 proteins, in a Keratinocyte 
Growth Factor (KGF) dependent manner. By depleting stromal fibroblasts of each of 
the three AKT isoforms independently, or through using isoform specific inhibitors, 
we determined that stromal AKT2 is an essential regulator of invasion and show in 
oro-pharyngeal cancers that AKT2 specific phosphorylation events are also identified 
in stromal fibroblasts. Depletion of stromal AKT2 inhibits epithelial invasion through 
activating a protective pathway counteracting KGF mediated invasions. AKT2 depletion 
in fibroblasts stimulates the cleavage and release of IL1B from stromal fibroblasts 
resulting in down-regulation of the KGF receptor (fibroblast growth factor receptor 
2B (FGFR2B)) expression in the epithelium. We also show that high IL1B is associated 
with increased overall survival in a cohort of patients with oro-pharyngeal cancers. 
Our findings demonstrate the importance of stromal derived growth factors and 
cytokines in regulating the process of tumour cell invasion. 
INTRODUCTION
Cancer is a disease of transformed epithelial 
cells but in recent years the importance of the stromal 
compartment in influencing the proliferation and invasive 
capacity of cancer epithelial cells, has become apparent. 
In normal stratified epithelium, Maas-Szabowski et al. 
suggested that the communication between the epithelium 
and the stromal fibroblasts is mainly based on the release 
of cytokines and growth factors, which are essential for 
epithelial maturation [1, 2]. They and others proposed that 
by releasing Interleukin-1alpha (IL1A) and Interleukin-
1beta (IL1B), epithelial keratinocytes stimulate the 
release of Keratinocyte Growth Factor (KGF, also known 
as fibroblast growth factor 7, FGF7) by the stromal 
fibroblasts and KGF in turn, is required to influence 
keratinocyte differentiation and proliferation [2-4]. Further 
studies revealed, that as well as controlling keratinocyte 
differentiation and proliferation, KGF also regulates 
invasion of pre-malignant keratinocytes [5].  
AKT can be activated in cells by reduced levels or 
mutations in Phosphatase and Tensin homology protein 
(PTEN) and increased activity through mutations of the 
subunits of Phosphatidylinositide 3-kinases (PI3 kinases) 
and it has recently been reported that loss of stromal PTEN 
dramatically increases mammary tumour formation in a 
MMTV-ErbB2 breast cancer model in mice [6, 7]. Also, 
the AKT pathway is modulated in the stroma of human 
breast cancers through mutation of PTEN and PI3K [8]. 
In addition, Pickard et al. showed that active AKT in the 
stromal fibroblasts correlated with increased invasive 
potential of HPV 16 E6 and E7 expressing, pre-malignant 
epithelium [5] AKT has three distinct isoforms, which 
even though they share a high percentage of homology 
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are known to have individual functions [9]. Knockout 
mouse models demonstrate the diversity of each isoform, 
as AKT1 knockout mice exhibit severe growth defects 
and 40% die during the first weeks of life [10]. On the 
other hand, AKT2 knockout mice have deficiencies in 
glucose metabolism and adipogenesis [11, 12] and AKT3 
knockout mice suffer from a deficiency in brain growth 
and development [13]. Although these mouse models 
might implicate a difference in tissue expression of the 
AKT isoforms, further studies have revealed roles for all 
three isoforms in regulating tumourigenesis in various 
tissues [14]. In spite of the growing importance of stromal 
PTEN and PI3 kinases, which isoform of AKT mediates 
these stromal effects is yet to be investigated. 
Here we propose a role for stromal AKT2 in 
regulating the cross-talk between stroma and epithelium 
and thereby controlling invasiveness of potentially 
malignant epithelium. Our findings suggest that loss of 
PTEN function in stromal fibroblasts induces epithelial 
invasions in an AKT2 and KGF dependent matter, the 
latter growth factor promoting invasion. Depletion of 
AKT2 inhibits invasion but surprisingly does not alter 
KGF levels.  However, AKT depletion does cause an 
increase in IL1B, which inhibits the function of KGF 
by reducing the expression of its receptor, FGFR2b, in 
tumour cells.  The overall result is the inhibition of AKT2-
mediated epithelial cell invasion.  
RESULTS
AKT is activated in the stroma associated with 
Head and Neck cancers
To investigate whether stromal AKT activation is 
important in oro-pharyngeal tumours, matched normal and 
tumour samples from 34 oro-pharyngeal tumour samples 
were stained with pAKT (Ser 473) as a readout of AKT 
activity [15] and Fibroblast Specific Protein 1 (FSP1) as a 
marker for stromal fibroblasts (Figure 1A). From this the 
percentage of stromal fibroblasts containing active AKT 
was determined. Approximately 75% of FSP1 positive 
fibroblasts contained active AKT when associated with 
the tumour, a seven-fold increase compared to fibroblasts 
associated with the matched histologically normal 
epithelium (Figure 1B). A small proportion of pAKT 
staining in the stroma did not correlate with FSP1 staining, 
or with either vimentin (Supplemental Figure S1A and B), 
or smooth muscle actin-positive cells (data not shown) and 
may represent infiltrating immune cells. 
Expression of AKT in stromal fibroblasts is crucial 
for invasion of pre-malignant keratinocytes
To investigate the impact of stromal AKT activation 
on epithelial invasions, we used three-dimensional 
organotypic raft cultures, where human fibroblasts 
are placed in a collagen plug that acts as the stroma 
and keratinocytes seeded on top of the collagen as the 
epithelial layer. To activate AKT, we depleted PTEN 
levels in primary human foreskin fibroblasts (HFFs) using 
retrovirally expressed short-hairpin RNA (shRNA) and 
reduced PTEN protein levels were confirmed by western 
blot along with the corresponding activation of AKT, as 
shown by pAKT (Ser 473) levels (Figure 1C).  To assess 
the effect of PTEN depleted fibroblasts on epithelial 
growth, primary human foreskin keratinocytes (HFK) were 
transformed with a retroviral vector expressing the Human 
Papilloma Virus (HPV) Type 16 E6 and E7 proteins, 
which results in immortalized but non-tumourigenic cells 
[5]. Organotypic raft cultures were grown for 14 days, 
after which they were fixed and Heamatocylin and Eosin 
(H + E) stained to determine the level of invasion. In raft 
cultures containing fibroblasts expressing a scramble 
control sequence (shSCR), keratinocytes infrequently 
invaded into the collagen plug (Figure 1D).  However, 
using two different short hairpin RNAs (shRNA) to PTEN, 
we observed invasion of the immortalized keratinocytes 
in PTEN depleted fibroblasts (Figure 1D) that were 
subsequently counted and quantification (Figure 1E). 
These experiments have been carried out using three 
independently generated HFFs and E6/E7 expressing 
HFKs.
AKT2 mediates invasions.
To investigate if AKT was involved in stimulating 
invasion, we used a siRNA targeted to all three AKT 
isoforms. Depletion was confirmed by real-time PCR and 
Western blot (Supplemental Figure S2A and S2B) and 
the fibroblasts transferred into collagen plugs to examine 
their effect on pre-malignant keratinocyte invasions. By 
depleting PTEN knockdown fibroblasts of all three AKT 
isoforms, invasion of E6/E7-expressing keratinocytes 
was inhibited (Supplemental Figure S2C and S2D), 
confirming that the invasive phenotype mediated by 
PTEN knockdown fibroblasts is indeed an AKT dependent 
function.  
AKT has three isoforms; AKT1, AKT2 and AKT3 
and although their functions often overlap, they have 
been shown to have individual roles regarding invasion 
and metastasis [16, 17]. To establish whether this holds 
true in a cell non-autonomous fashion and to determine 
which isoform mediates invasion, AKT isoforms were 
knocked down in HFFs depleted of PTEN using individual 
short interfering RNA (siRNA) molecules. Knockdown 
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of individual isoforms was confirmed using real-time 
PCR and Western blots (Figure 2A and B). Fibroblasts 
were then transferred into collagen plugs and used in 
organotypic raft cultures. Knockdown was retained 
after 14 days of culture as determined by real-time PCR 
(Supplemental Figure S3A-C), due to the fact that the 
fibroblasts in the collagen plug do not proliferate.  Whilst 
knockdown of AKT1 and AKT3 did not alter keratinocyte 
invasions, knockdown of AKT2 significantly reduced 
keratinocyte invasions to levels of control rafts (Figure 2C 
Figure 1: Stromal fibroblasts in oro-pharyngeal cancers contain activated AKT A) Oro-pharyngeal tumour samples 
were stained with anti-pAKT (Ser 473) and anti-Fibroblast Specific Protein 1 (FSP1).  White arrows show cells staining 
positive for both pAKT (Ser 473) and FSP1. Scale bar = 25 µm. B) Quantification of staining, where cells were counted as follows: all 
FSP1 positive cells were counted (to a total of 600 cells per normal and tumour section each per slide). Cells stained for both pAKT (Ser 
473) and FSP1 were also counted. The histogram shows the percentage of cells that were pAKT(Ser 473) and FSP1 positive out of all FSP1 
positive cells. C) Knockdown of PTEN in primary human foreskin fibroblasts. Western blot analysis shows knockdown and subsequent 
increase in active, phosphorylated AKT at Ser 473. D) Organotypic raft cultures of scramble control and PTENa and PTENb knockdown 
fibroblasts cultured with E6/E7-expressing keratinocytes showing invasion of keratinocytes. Arrows distinguish the basal membrane. Scale 
bar = 100µm.  E) Quantification of invasions per cm of raft in relation to the scramble control raft culture shows an induction of invasions 
after loss of PTEN in stromal fibroblasts.  P-values: *=p<0.05; ***=p<0.001.  All experiments were repeated 3 times.  
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and D).  Hence, knockdown of AKT2 was able to inhibit 
stromal fibroblast mediated invasions, indicating that these 
invasions are AKT2 dependent. To further confirm the 
role of stromal AKT2 in mediating epithelial invasions, 
we also used specific inhibitors of AKT1 and AKT2 
(Figure 3A) to show that only inhibition of AKT2 reduced 
the level of invasion of PTEN depleted rafts (Figure 
3B and C). We also exogenously expressed HA-AKT 
isotypes and a catalytically inactive HA-AKT2 molecule 
in HFFs (Supplemental Figure S4A) and assessed 
epithelial invasion (Supplemental Figure S4B). Only 
expression of the active AKT2 was able to significantly 
increase invasion of the E6/E7-expressing keratinocytes 
(Supplemental Figure S4C).  
To investigate whether activation of stromal AKT2 
may be important in tumourigenesis of oro-pharyngeal 
cancers, tumour sections were co-stained with antibodies 
raised against pAKT (Ser 473) and AKT2 (Figure 4A). 
Dual stained cells were counted in stroma associated 
with normal and tumour tissue and demonstrated a 
significant increase in the proportion of AKT2 positive 
cells, that were also positive for pAKT (Ser 473) in 
tumour associated stroma (Figure 4B). To further confirm 
this observation, we used an antibody, which detects the 
phosphorylation of MDM2 at the Serine 166 residue, as 
this had previously been reported to be an AKT2 specific 
phosphorylation event [18]. To confirm that MDM2 
(Ser 166) was indeed an AKT2 specific phosphorylation 
Figure 2: Depletion of individual AKT in PTEN knockdown HFFs.  PTEN knockdown fibroblasts were depleted of AKT1, 
AKT2 and AKT3 and knockdown was confirmed by A) real-time PCR analysis and B) Western blots.  C) Organotypic raft co-cultures using 
E6/E7 expressing keratinocytes and PTEN depleted fibroblasts that were treated with either siRNA molecules directed against scramble 
control (siScr), AKT1 (siAKT1), AKT2 (siAKT) and AKT3 (siAKT).  Scale bar = 100µm.  Panels are representative of three separate 
experiments. D) Quantification of invasions per cm of raft in relation to the scramble control raft culture.  
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site, cell lysates from PTEN and AKT isoform depleted 
fibroblasts were analysed by western blot analysis (Figure 
4C). Phosphorylated MDM2- ser 166 is increased in 
PTEN depleted fibroblasts, which is then reduced upon 
additional knockdown of AKT2. This was not observed in 
cells where AKT1 or AKT3 were depleted, confirming that 
this site is AKT2 specific.  Using pMDM2 (Ser 166) as an 
indicator of AKT2 activity matched normal and tumour 
oro-pharyngeal tumour sections were co-stained with 
pAKT (Ser 473) (Figure 4D) and this revealed a strong 
correlation between active AKT and pMDM2 (Ser 166) 
in tumour stroma compared to normal stroma (Figure 4E). 
These results indicate that AKT2 is activated in the stroma 
of oro-pharyngeal cancers, correlating with our findings in 
organotypic raft cultures.  
We had previously shown that in fibroblasts depleted 
of the retinoblastoma protein (Rb), AKT was activated 
and induced invasion of E6/E7-expressing keratinocytes 
through a KGF-dependent mechanism [5]. To determine 
if invasion was mediated by KGF in PTEN depleted 
fibroblasts, we depleted KGF in PTEN knockdown cells 
and showed that, as with Rb depleted cells, invasion of 
epithelial cells was mediated by KGF (Supplemental 
Figure S5A-C).  
IL1B prevents KGF mediated invasions
Since AKT mediated invasions were KGF 
dependent, we next examined KGF levels in PTEN and 
AKT isoform depleted fibroblasts to determine if AKT2 
activity was responsible for the increase in KGF that 
resulted in invasion. While there was an increase in KGF 
mRNA levels upon PTEN knockdown, KGF mRNA 
levels (Figure 5A) and protein (data not shown) were 
not significantly altered when AKT1, AKT2 or AKT3 
where knocked down individually in addition to PTEN. 
However, KGF levels were reduced to control levels upon 
knockdown of all three isoforms simultaneously (Figure 
5B), showing that KGF expression is AKT dependent, but 
that the AKT isoforms can possibly compensate for each 
other in the regulation of KGF expression. Compensation 
between isoforms has also been shown in AKT1/AKT2 
double knockout mice, which suffer from severely 
impaired skin development, not seen in single knockout 
mice [19]. 
Figure 3: An AKT2 inhibitor reduces invasion. A) The activity and specificity of inhibitors to AKT 1 and 2.  B) Inhibitors specific 
for AKT1 (AKTi) and AKT2 (AKT2i) were used to treat organotypic cultures containing depleted PTEN HFFs.  Scale bar = 100µm.  C) 
Quantization shows that only cultures treated with the AKT2 inhibitor (AKT2i) had reduced invasion of E6/E7 expressing HFKs.  P values: 
**=p<0.01.  ns = not significant.  All experiments were repeated 3 times.  
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KGF is not the only growth factor/cytokine involved 
in the paracrine cross-talk between stromal fibroblasts 
and epithelium [2]. IL1A and IL1B have previously been 
shown to stimulate fibroblasts to produce KGF [1]. To 
establish IL1 levels in AKT2 depleted fibroblasts, the 
mRNA levels of both IL1A and IL1B were examined 
using quantitative real-time PCR. Similarly to KGF 
levels, an increase in IL1A levels was observed when 
PTEN was depleted in HFFs (Figure 6A). Knockdown of 
any of the AKT isoforms decreased IL1A levels to that of 
Figure 4: Stromal fibroblasts in oro-pharyngeal cancers exhibit activated AKT2.  A) Oro-pharyngeal tumour samples were 
stained with anti-pAKT (Ser 473) and AKT2.  Scale bar = 25 µm.  B) The histogram shows quantification of staining, where cells were 
counted as follows: all AKT2 positive cells were counted (to a total of 600 cells per normal and tumour section each per slide). Cells that 
stained for both pAKT (Ser 473) and AKT2 were also counted. The histogram shows the percentage of cells that were pAKT (Ser 473) 
and AKT2 positive out of all AKT2 positive cells.  C) PTEN knockdown fibroblasts were depleted of AKT1, AKT2 or AKT3. Western blot 
analysis shows pMDM2 (Ser 166) levels as an indicator of AKT2 activity. D) Oro-pharyngeal cancer biopsy sections were co-stained with 
pAKT (Ser 473) and pMDM2 (Ser 166) conjugated to a fluorophore. White arrows indicate representative cells stained with pAKT and 
pMDM2.  Scale bar = 25 µm.  E) Quantification of staining, where cells were counted as follows: all pAKT (Ser 473) positive cells were 
counted (to a total of 600 cells per normal and tumour section each per slide). Cells that stained for both pMDM2 (Ser 166) and pAKT (Ser 
473) were also counted. The histogram shows the percentage of cells that were pMDM2 (Ser 166) and pAKT (Ser 473) positive out of all 
pAKT (Ser 473) positive cells. P-values: ***=p<0.001. 
Oncotarget 2013; 4: 1103-11161109www.impactjournals.com/oncotarget
the scrambled control (Figure 5A). Examination of IL1B 
levels revealed that the increased IL1B levels observed in 
PTEN depleted fibroblasts were mediated by either AKT1 
or AKT3, while depletion of AKT2 resulted in a further 
increase in IL1B (Figure 6B). ELISA confirmed this 
result, which also revealed, that the increase in IL1B levels 
detected in PTEN only knockdown fibroblasts (Figure 
6B) did not result in increased secretion of the protein 
(Figure 6C). However, the increased mRNA expression 
levels upon further depletion of AKT2 in fibroblasts were 
translated into secreted IL1B protein (Figure 6C) and so 
implicate AKT2 in the regulation of IL1B translation/
secretion. To investigate this further, we determined the 
level of caspase 1, Interleukin-1 cleaving enzyme (ICE), 
which cleaves IL1B and allows secretion of the active 
protein. Figure 6D shows that caspase 1 protein levels are 
elevated specifically in cells depleted of AKT2 and not 
in cells depleted of AKT1 or 3. This was not observed 
at the transcriptional level (Figure 6E), suggesting AKT2 
regulates Caspase 1 levels via a post-transcriptional 
mechanism. Following immunoprecipitation of Caspase 
1 from conditioned medium from these cells, the active 
fragment of Caspase-1 could be observed (Figure 6F). 
Therefore, the depletion of both PTEN and AKT2 resulted 
in increased expression and release of active IL1B, 
while the depletion of PTEN and AKT1 or 3 increased 
expression of IL1B without releasing the active form.
We hypothesised that the increased levels of IL1B 
in the PTEN/AKT2 depleted cells might have a protective 
effect on the invasion process.  To determine the effect 
of IL1B on invasion we treated organotypic raft cultures 
containing either scramble control or PTEN knockdown 
fibroblasts with 20 ng/ml of recombinant IL1B. The 
amount of IL1B used was determined based on previous 
reports investigating IL1B levels in healthy dental pulps 
[20]. Whilst IL1B had no effect on the epithelium grown 
with control fibroblasts, IL1B treatment of cultures 
grown with PTEN depleted HFFs resulted in a significant 
reduction in the number of invasive events (Figure 7A and 
B). This was further confirmed by treatment of PTEN/
AKT2 depleted fibroblast cultures with the IL1 receptor 
antagonist (IL1RA), to sequester the secreted IL-1B and 
preventing binding to the IL1 receptor. Through blocking 
IL1B signalling keratinocyte invasion was induced (Figure 
7C and D), indicating that IL-1B had an inhibitory effect 
on invasion. This could be specifically attributed to IL1B 
through knockdown of IL1B in PTEN/AKT2 double 
knockdown fibroblasts, which again induced keratinocyte 
invasion (Supplemental Figure S6A and B). These results 
demonstrated that AKT2 depletion activates a protective 
pathway, mediated by IL1B, which inhibits the pro-
invasive KGF pathway and implies that AKT2 depletion 
leads to the inactivation of this normally protective 
pathway. 
IL1B inhibits epithelial FGFR2B expression and 
increases overall survival
IL1B inhibited invasion in our model system, so to 
determine if the levels of IL1B in oro-pharyngeal cancers 
had a protective effect, we examined the mRNA levels 
of IL1B by real-time PCR in matched non-tumour and 
tumour tissue from 22 oro-pharyngeal cancers. To take into 
account that these samples include a mixture of epithelial 
and stromal content, FSP1 expression was determined 
as a measure of the content of stroma. IL1B levels were 
normalised to ribosomal protein large P0 (RPLPO) and 
then to FSP1. The difference in the expression of IL1B 
in the tumour and matched non-tumour samples was 
calculated and correlated to patient overall survival. 
Enhanced expression of IL1B in the tumour-associated 
stoma compared to the stroma from matched non-tumour 
tissue showed a more favourable outcome than those with 
reduced expression of IL1B in the tumour associated 
stroma (Figure 8A). 
Since IL1B inhibited invasion even in the presence 
of elevated KGF levels we investigated whether IL1B 
influenced KGF mediated signalling. We therefore 
investigated whether IL1B treatment altered the expression 
Figure 5: KGF mRNA levels in AKT depleted cells: A) Scramble control, PTEN, and PTEN and either AKT1, AKT2 and 
AKT3 knockdown fibroblasts were analyzed using real-time PCR analysis for KGF mRNA levels. B) PTEN knockdown 
fibroblasts were depleted of all three AKT isoforms (shPTEN/siTAKT) and KGF mRNA levels were examined using real-time PCR.  
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of FGFR2B.  E6/E7 expressing keratinocytes were 
treated with KGF alone, IL1B alone, or a combination 
of KGF and IL1B.  KGF treatment resulted in increased 
expression of FGFR2B mRNA levels over a 96-hour time 
course (Figure 8B), in comparison IL1B treatment did not 
alter the expression of FGFR2B (Figure 8C).  However, 
when cells were treated with KGF in the presence of 
IL1B, there was no induction of FGFR2b expression in 
fact there was a significant reduction in FGFR2B levels 
in keratinocytes both at the level of mRNA and protein 
(Figure 8D and E).  These data suggest that the IL1B 
signalling pathway can inhibit KGF signalling by reducing 
KGF dependent FGFR2B expression.  To further evaluate 
this hypothesis in the organotypic culture model, the 
epithelia was removed from organotypic cultures grown 
in the presence of PTEN depleted fibroblasts plus each 
of the individual AKT isoforms and the expression of 
FGFR2B was examined by real-time PCR and western 
blot analysis.  Epithelia cultured with PTEN/scr, PTEN/
AKT1 and PTEN/AKT3 knockdown fibroblasts, showed 
Figure 6: IL1B expression, cleavage and release in PTEN/AKT2 depleted fibroblasts. A) IL1A levels were determined 
in fibroblasts depleted for PTEN and each single AKT isoform using real-time PCR. B) As in (A) but IL1B levels are shown. C) ELISA 
analysis for IL1B in media from organotypic cultures where the fibroblast cells were depleted of PTEN and individual AKT isoforms. 
Media was concentrated 14 times before ELISA was performed. Figure is average of two separate experiments. D) Western blot showing 
increase in caspase 1 in PTEN/AKT2 depleted fibroblasts.  E) mRNA levels of IL1B show that expression of Caspase 1 is not significantly 
different in fibroblasts depleted of PTEN and each of the individual AKT isoforms.  F) Shows the increase in the cleaved form of caspase 
1 in PTEN/AKT2 depleted fibroblasts.
Oncotarget 2013; 4: 1103-11161111www.impactjournals.com/oncotarget
an increase in FGFR2B expression compared to controls 
(scr/scr), whereas epithelia from PTEN/AKT2 knockdown 
fibroblast-containing stroma showed a decrease in 
FGFR2B expression to that of the controls (Figure 8F and 
8G).  Since we had previously shown that FGFR2B was 
required for invasion [5], these current results show that 
IL1B can inhibit invasion through down-regulation of the 
FGFR2B receptor.
DISCUSSION
The work presented here, using 3D organotypic 
cultures and tumour tissue, support evidence indicating 
cell non-autonomous roles for AKT in tumourigenesis. 
We have shown AKT activation in primary human 
fibroblasts results in invasion of the epithelium and 
supports the recent findings in mouse breast tissue [7], 
where conditional PTEN knockdown in FSP1 expressing 
stromal fibroblast cells, resulted in enhanced tumour 
formation.  We have gone on to show for the first time that 
stromal AKT function is required to regulate expression 
of KGF, a driver of epithelial invasion.  Our findings are 
confirmed by analysis of microarray data from the stromal 
compartment associated with mammary tumours in 
mice with PTEN-depleted fibroblasts which also express 
elevated levels of KGF (GEO Dataset GSE16073, [7]). 
We have also observed that in stromal fibroblasts, AKT 
is activated in areas surrounding tumour epithelium in 
oro-pharyngeal cancers.  Using organotypic raft cultures 
we have shown that the invasion induced by AKT 
activation is due to AKT2.  This has been shown in three 
ways, firstly, depletion of AKT2, secondly, inhibition of 
invasion by an AKT2 specific inhibitor and thirdly, over-
expression of AKT2. This work is also in agreement with 
experiments conducted in the cancer epithelium, where 
AKT2 has been shown to be a key regulator of invasion 
and metastasis [21]; the specific function of AKT2 in 
regulating the invasion process may be related to the 
specific phosphorylation targets of the kinase, such as 
mdm2, but may also be subject to cellular stresses such as 
Figure 7: IL1B inhibits invasion.  A) Organotypic raft co-cultures using scramble control and PTEN knockdown fibroblasts and 
E6/E7-expressing keratinocytes. Raft cultures were treated with 20 ng/ml of IL1B.  Scale bar = 100µm.  Organotypic raft cultures are a 
representative of 3 biological replicates.  B) Quantification of invasions into the collagen matrix per cm of raft culture from (A) relative 
to scramble control raft cultures from three independent experiments. C) Organotypic raft co-cultures using scramble control, PTEN 
knockdown fibroblasts and PTEN/AKT2 knockdown fibroblasts and E6/E7 expressing keratinocytes. PTEN/AKT2 fibroblasts raft cultures 
were treated with 20 ng/ml of IL1RA.  Scale bar = 100µm.  Organotypic raft cultures are a representative of 3 biological replicates. D) 
Quantification of invasions into the collagen matrix per cm of raft culture relative to scramble control raft cultures from three independent 
experiments. P value: *=p<0.05.  ns=not significant.  
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oxidation which could uniquely activate AKT2  [22, 23].
Recently, we had previously shown that when AKT 
is activated in fibroblasts in organotypic rafts, there is a 
concomitant increase in KGF expression [5] implicating 
AKT signalling pathways in the regulation of KGF 
expression.  Here we have shown that knockdown of all 
AKT isoforms in PTEN depleted fibroblasts was sufficient 
to reduce KGF expression and invasion.  Interestingly, 
knockdown of individual AKT isoforms was not sufficient 
to disrupt the increase of KGF expression.  This suggests 
there is intricate interplay between the different AKT 
isoforms and that loss of one isoform can be compensated 
for by the other family member, as has previously been 
observed in knockout animals [14] where individual 
knockout mice are viable; however, the AKT1 and 
AKT2 double knockout mice died in utero at day 18.5 
and suffered from severe skin development [19].  While 
we have found that depletion of AKT2 was sufficient to 
abolish epithelial invasions mediated by PTEN depleted 
fibroblasts it did not alter KGF levels, suggesting that 
KGF-independent mechanisms are also able to regulate 
epithelial invasion.  
This KGF-independent mechanism was shown 
to be due to a dramatic increase in IL1B expression, 
accompanied by enhanced secretion of IL1B.  The 
enhanced secretion of IL1B was only observed in 
AKT2 depleted fibroblasts and was due to the increased 
expression of caspase 1 which is known to cleave IL1B 
resulting in secretion from cells.  Whilst IL1B is known 
to drive KGF expression in fibroblasts [1] the effects 
Figure 8: A) mRNA was obtained from 22 oro-pharyngeal tumour biopsies and matched non-tumour tissue and IL1B 
and FSP1 levels were determined using real-time PCR analysis.  Patients with high levels of IL1B in the tumour-associated 
stroma compared to the stroma associated with non-tumour tissue had a better overall survival.  B) Real-time PCR analysis of FGFR2B 
expression levels after KGF treatment of E6/E7-expressing cells.  C) Real-time PCR analysis of FGFR2B expression levels after IL1B 
treatment of E6/E7 expressing cells. D) Real-Time PCR analysis of FGFR2B expression levels after combined KGF and IL1B treatment of 
E6/E7-expressing cells. E) Western blot analysis confirms the decreased expression of FGFR2B from (C).  F) PTEN knockdown fibroblasts 
were depleted of each AKT isoform using siRNA molecules and these fibroblasts were used in organotypic raft co-cultures containing E6/
E7-expressing epithelia. The epithelium was peeled off each raft culture and FGFR2B mRNA measured by real-time PCR.  G) Western blot 
analysis of epithelia examining FGFR2 protein expression. Western blot analysis is representative and real-time PCR analysis an average 
of 3 biological replicates. P values: *=p<0.05, **=p<0.01, ***=p<0.001. 
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of IL1B on the epithelium are not clearly defined.  The 
IL1 isoforms, IL1A and IL1B, have previously been 
described as both anti-invasive and pro-invasive, 
suggesting no clear indication of their role in cancer 
progression [24-26]; however, our findings report a new 
protective function for IL1B in tumour invasion.  We 
have demonstrated that treatment of AKT activated 
fibroblasts in organotypic cultures with recombinant IL1B 
inhibited epithelial cell invasion.  This inhibitory role of 
IL1B was further confirmed by treatment of PTEN and 
AKT2 double knockdown fibroblast raft cultures with the 
naturally occurring negative regulator of IL1 signalling, 
IL1RA, which sequesters IL1B, resulting in restoration 
of epithelial invasion.  Furthermore, examination of 
the oro-pharyngeal tumour samples at an mRNA level 
revealed that if IL1B is elevated in the stroma of the 
tumour compared to the stroma of matched non tumour 
tissue, patients have a more favourable outcome, than 
those where IL1B levels were reduced in the tumour 
samples.  Previous datasets from microarray experiments 
support our findings as they reveal a favourable outcome 
for ovarian and breast cancer patients who express high 
levels of IL1B [27, 28].  The protective effect of IL1B 
in our model system, was due to the reduced expression 
of the KGF receptor, FGFR2b, by IL1B.  Alterations of 
FGFR2B expression and single nucleotide polymorphisms 
have been implicated in a variety of cancers including 
breast, and gastric cancers [29-31] and here we show that 
the expression of FGFR2B correlates with the invasive 
behaviour of keratinocytes. This interplay between 
stromal fibroblasts and cancer cells has been shown in 
other cancers and in addition to regulating invasion, these 
interactions can change metabolism of tumour and stromal 
cells [32, 33]. 
In summary, our results show a crucial role for 
stromal AKT in regulating epithelial invasion, with AKT2 
having an essential role in driving keratinocyte invasion 
from the stromal compartment.  The adverse effects of 
AKT activation in the stroma can be counteracted by 
IL1B through down-regulation of the KGF receptor and 
so in cancer a balance between the pro-invasive AKT and 
KGF pathway and the anti-invasive IL1B levels within 
the stroma will drive the epithelium to either a more or 
less aggressive phenotype.  The results suggest that AKT2 
inhibitors may be effective in inhibiting invasion in oro-
pharyngeal cancers
MATERIALS AND METHODS
Reagents
Total AKT (9272) and AKT p-473 (9271) antibodies 
were purchased from Cell Signaling Technology 
(Boston, MA, USA).  FSP1 (sc-100784), FGFR2 (sc-
122) antibodies and horseradish peroxidase conjugated 
secondary antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). pMDM2 (Ser 
166) and beta-actin (AC74) antibodies were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). The 
following sequences were used to produce pSUPER.puro 
(OligoEngine, Seattle, WA, USA) retroviral vectors for 
stable RNA interference: PTEN 5’ TCC TGC AGA AAG 
ACT TGA AG 3’. shRNA targeting KGF was purchased 
from Origene (TR312988, puromycin selection, molecules 
3 and 4)(Rockville, MD, USA). The following sequences 
were used for transient RNA interference: AKT1 5’ GGA 
CGG GCA CAT TAA GAT CTT 3’, AKT2 5’ GAA GTG 
GCG GTC AGC AAGG 3’, AKT3 5’ GGC AAG AUG 
UAU AUG AUA A dT dT 3’. siRNA targeting total AKT 
(6211) was purchased from Cell Signalling Technology 
(Boston, MA, USA). Recombinant IL1B and IL1RA 
was purchased from Cell Signaling Technology (Boston, 
MA, USA).  Akt1i and Akt2i were provided by Almac 
Discovery, Craigavon, Northern Ireland.
Cell culture and stable/transient knockdown 
fibroblasts and immortalised keratinocytes
Primary Human Foreskin Fibroblasts, purchased 
from Cascade Biologics, and φnyx GP cells were 
maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% FBS, 1% Penicillin-
Streptomycin solution and Amphotericin. Primary 
Human Foreskin Keratinocytes (HFK) were isolated 
as previously described [34] and maintained in Epilife 
media supplemented with Human Keratinocyte Growth 
Supplement (Invitrogen, Paisley, UK), 1% Penicillin-
Streptomycin solution and Amphotericin. Organotypic 
raft cultures were generated as previously described [35] 
and cultured for 14 days, before being processed and 
Heamtoxylin and Eosin stained to standard protocols. 
Stable knockdown fibroblasts were generated using the 
φnyx system as described before [36]. Cells containing 
shRNA targeted towards PTEN were selected with 1.25 
µg/ml puromycin.  Cells containing shRNA targeted 
to KGF were selected using 3mg/ml Blasticidin.  E6/7 
keratinocytes were generated as previously described [37].
Transient knockdown was achieved by using 100 
nM siRNA per 90mm dish of fibroblasts. siRNA was 
transfected using Polyethylenimine (PEI) at a ratio of 3µl 
to 100 nM siRNA. Fibroblasts were harvested 72 hours 
after transfection.
Immunofluorescent staining and western blot 
analysis
Invasions were counted along the raft culture 
sections following H+E staining. Immunofluorescent 
staining of tumour samples was conducted as previously 
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described [5], imaged using a DMI 6000B microscope 
and DFC-350 FX camera and visualised using LAS 
AF software (Leica Microsystems, Wetzlar, Germany). 
pAKT (Ser 473), AKT2, and FSP1 Antibodies were used 
at a concentration of 1:100, pMDM2 (Ser 166) antibody 
was used at concentration of 1:200 with an overnight 
incubation. For experiments shown in Figure 3D pMDM2 
(Ser 166) antibody was conjugated using a fluorophore 
conjugation kit purchased from Biotium (Hayward, CA, 
USA).
 Western blot analysis was performed as previously 
described [36]. Typically 50 µg of total protein was used 
to perform western blot analysis.  
Reverse-Transcription PCR analysis
RNA from cells and organotypic rafts was harvested 
using Trizol® (Life Technologies, Paisley, UK), while 
RNA from tissues was extracted using DNeasy Blood 
and Tissue kit (Qiagen, Crawley, UK) followed by 
Trizol extraction with linear acrylamide according to the 
manufacturer’s instructions (Life Technologies, Paisley, 
UK ) .  Reverse transcription was performed using M-MLV 
Reverse Transcriptase kit (Life Technologies, Paisley, 
UK). PCR analysis was performed using LightCycler® 
480 SYBR Green I Master (Roche, Basel, Switzerland) 
according to manufacturer’s guidelines. The following 
primer sets were used for analysis: AKT1: F: 5’-ATG ATG 
TGC GGT CGC CTG CC- 3’; R:  5’TGG GGC TTG AAG 
GGT GGG CT3’, AKT2: F: 5’-AGT GGC GGT CAG 
CAA GGC AC-3’; R: 5’-TCA GCG CAG TGA GGA ACG 
GG-3’, AKT3:F: 5’-TGG TGG GGC CTA GGG GTT GT-
3’; R: 5’-TGG TCC TCC ACC AAG GCG TTT-3’, KGF: 
F:5’-CAC AAA TGG ATA CTG ACA TGG-3’;R: 5’-TCA 
CTC TTA TAT CCC CTC CTT C-3’, IL1A: F: 5’-ATC 
CTT CTA TCA TGT AAG CTA TGG-3’; R: 5’-TCC TCT 
GAG TCA TTG GCG AT-3’, IL1B: F: 5’ TAC CTG TCC 
TGC GTG TTG AA 3’; R: 5’ TCT TTG GGT AAT TTT 
TGG GAT CT 3’, FGFR2B: F: 5’ CCT GCC AAA ACA 
GCA AGC 3’; R: 5’ AAG ACC CCT ATG CAG TAA ATG 
G 3’. The following controls were used RPLPO: F: 5’-
ATC AAC GGG TAC AAA CGA GTC-3’; R: 5’-CAG 
ATG GAT CAG CCA AGA AGG-3’. 
ELISA analysis 
IL1B ELISA was supplied by ebioscience (San 
Diego, CA, USA) and conducted according to the 
manufacturer’s protocol.  IL1B levels were quantified 
against a standard curve of recombinant human IL1B. 
Medium from organotypic raft cultures was concentrated 
14 times before being applied to the ELISA.  
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